{"id":"https://openalex.org/W2353530496","doi":null,"title":"Research progress on the effects of glucagon like peptide-1 in metabolic cardiovascular disease","display_name":"Research progress on the effects of glucagon like peptide-1 in metabolic cardiovascular disease","alternate_titles":[],"publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2353530496","mag":"2353530496"},"language":"en","primary_location":{"id":"mag:2353530496","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=JFJY201405026","pdf_url":null,"source":{"id":"https://openalex.org/S2739286045","display_name":"Jiefangjun yixue zazhi","issn_l":"0577-7402","issn":["0577-7402"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310311953","host_organization_name":"Editorial Board of Medical Journal of Chinese People's Liberation Army","host_organization_lineage":["https://openalex.org/P4310311953"],"host_organization_lineage_names":["Editorial Board of Medical Journal of Chinese People's Liberation Army"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Jiefangjun yixue zazhi","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2353530496"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100450779","display_name":"Xi Liang","orcid":"https://orcid.org/0000-0001-7430-1242","observed_orcids":["https://orcid.org/0000-0001-7430-1242"]},"institutions":[{"id":"https://openalex.org/I151075929","display_name":"Army Medical University","ror":"https://ror.org/05w21nn13","country_code":"CN","type":"education","lineage":["https://openalex.org/I151075929"]},{"id":"https://openalex.org/I4210092099","display_name":"Daping Hospital","ror":"https://ror.org/00fthae95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210092099"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Liang Xi","raw_affiliation_strings":["Department of Hypertension and Endocrinology,Chongqing Institute of Hypertension,Center for Hypertension and Metabolic Diseases,Daping Hospital,Third Military Medical University"],"raw_orcid":"https://orcid.org/0000-0001-7430-1242","affiliations":[{"raw_affiliation_string":"Department of Hypertension and Endocrinology,Chongqing Institute of Hypertension,Center for Hypertension and Metabolic Diseases,Daping Hospital,Third Military Medical University","institution_ids":["https://openalex.org/I151075929","https://openalex.org/I4210092099"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5100450779"],"corresponding_institution_ids":["https://openalex.org/I151075929","https://openalex.org/I4210092099"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12979","display_name":"Cardiovascular Disease and Adiposity","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.984000027179718},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9879999756813049},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9120000004768372},{"id":"https://openalex.org/keywords/cardiovascular-complications","display_name":"cardiovascular complications","score":0.9110000133514404},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.47999998927116394},{"id":"https://openalex.org/keywords/lipid-lowering","display_name":"lipid lowering","score":0.7110000252723694},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.6880000233650208},{"id":"https://openalex.org/keywords/endothelial-function","display_name":"endothelial function","score":1.0},{"id":"https://openalex.org/keywords/myocardial-ischemia","display_name":"myocardial ischemia","score":0.9789999723434448},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.9639999866485596},{"id":"https://openalex.org/keywords/cardioprotection","display_name":"cardioprotection","score":0.8399999737739563}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8016045093536377},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6433268785476685},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5551198720932007},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5405044555664062},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5393471717834473},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.522554337978363},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.5167140364646912},{"id":"https://openalex.org/C541997718","wikidata":"https://www.wikidata.org/wiki/Q188151","display_name":"Ischemia","level":2,"score":0.4266677498817444},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.41990137100219727},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.414610892534256},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.248896986246109}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2353530496","doi":null,"is_oa":false,"landing_page_url":"https://oversea.cnki.net/kcms/detail/detail.aspx?dbcode=CJFD&filename=JFJY201405026","pdf_url":null,"source":{"id":"https://openalex.org/S2739286045","display_name":"Jiefangjun yixue zazhi","issn_l":"0577-7402","issn":["0577-7402"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310311953","host_organization_name":"Editorial Board of Medical Journal of Chinese People's Liberation Army","host_organization_lineage":["https://openalex.org/P4310311953"],"host_organization_lineage_names":["Editorial Board of Medical Journal of Chinese People's Liberation Army"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Jiefangjun yixue zazhi","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2364754039","https://openalex.org/W3030237936","https://openalex.org/W2374627620","https://openalex.org/W2408319152","https://openalex.org/W4292340974","https://openalex.org/W3032142079","https://openalex.org/W2413305489","https://openalex.org/W3138099017","https://openalex.org/W4225894630","https://openalex.org/W2292763234"],"abstract_inverted_index":{"Cardiovascular":[0],"complications":[1,33],"are":[2,21],"mainly":[3],"responsible":[4],"for":[5,17],"high":[6],"mortality":[7],"in":[8],"patients":[9],"with":[10],"type":[11,18],"2":[12,19],"diabetes.":[13],"The":[14,88],"previous":[15],"treatments":[16],"diabetes":[20],"focused":[22],"on":[23,96],"lowering":[24],"of":[25,31,94],"blood":[26,53,61,68],"glucose,":[27],"however":[28],"the":[29,52,60,67,92],"incidence":[30],"cardiovascular":[32,97],"has":[34],"not":[35,57],"been":[36],"improved.":[37],"Glucagon":[38],"like":[39],"peptide-1(GLP-1)":[40],"receptor":[41],"agonists":[42],"and":[43,70,83,85],"their":[44],"analogues,":[45],"as":[46],"a":[47],"new":[48],"medication":[49],"to":[50],"reduce":[51,59,73],"glucose":[54,62],"level,":[55,63,72],"can":[56],"only":[58],"but":[64],"also":[65],"lower":[66],"pressure":[69],"lipid":[71],"body":[74],"weight,":[75],"improve":[76],"endothelial":[77],"function,":[78],"alleviate":[79],"myocardial":[80],"ischemia":[81],"injury":[82],"atherosclerosis":[84],"so":[86],"on.":[87],"present":[89],"paper":[90],"summarizes":[91],"effects":[93],"GLP-1":[95],"protection.":[98]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2353530496","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
